A triple-therapy combination inhaler for moderate to very severe COPD

Description

In this Product Explainer, Prof Christine Jenkins, Head of the Respiratory Group at The George Institute for Global Health; and Senior Staff Specialist in Thoracic Medicine at Concord Hospital explains the role of a triple-therapy combination, pressurised meter dose inhaler for adults with moderate to very severe COPD. (4 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Samantha Hocking

A/Prof Samantha Hocking

Tirzepatide Compared to Semaglutide for Treatment of Obesity – Latest Evidence

A/Prof Gino Pecoraro OAM

A/Prof Gino Pecoraro OAM

Genitourinary Syndrome of Menopause – Mythbusting for GPs

Prof Sonia Grover

Prof Sonia Grover

Dysmenorrhoea in Teens

Prof Paul Griffin

Prof Paul Griffin

Winter Virus Preparations

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Christine Jenkins

expert

Prof Christine Jenkins

Respiratory Physician; Head, Respiratory Group, The George Institute for Global Health

Date published: 24 January 2022